Miro Sciences Ltd

A$0.05As of Sun 8 Nov 2026, 12:00 UTC
ASX:MSXHealthcare
Country Australia
PE (Fwd) •••
TSR 8Y CAGR (20.07%)
Div yield —
ROE (29.68%)
Biotechnology
Beta (5Y) 1.31
PE TTM —
TSR TTM (62.40%)
Mkt cap A$18.32M
ROIC (18.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0578
22.99%
(61.65%)
Hold 0|8|10|8|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
10.20%
15.77%
30.94%
28.34%
Revenue$M
1.219
1.263
1.330
1.360
1.61%
7.35%
11.26%
14.88%
Peers (US$12.58M)
Cap (US$)
PE
12.11M
—
Capital
TTM
5Y
10Y
Leveragex
0.243
0.797
0.580
EBIT/Intx
1.720
0.089
0.099
Own earn%
(54.29)
235.82
178.51
Sh yield%
8.20
22.39
25.03
Owners
Insiders/Inst%
2.58
26.34
Short interest%
5.67
SBC / revenue%
4.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
12–19
$1 testx
—
Incr. ROIC%
3